Biotech’s winners are big but so are its losers

Article Excerpt

Biotechnology is a science-driven industry that uses living organisms and molecular biology to produce healthcare-related products. Biotechnology is best known for its role in medicine and pharmaceuticals, but the science is also applied in other areas such as genomics, and the production of food and biofuels. The industry has undergone significant transformation over the past decade, driven by advances in science, technology, as well as expanded investment. These developments have not only revolutionized the treatment of diseases but also reshaped healthcare delivery and research. Key breakthroughs span gene editing, personalized medicine, mRNA technology, cell and gene therapies, and the integration of AI in drug discovery and diagnostics. But while the overall group of biotechnology companies have performed reasonably well over time, the gap between the returns of the winners and the losers was exceptionally wide. The reward for developing novel treatments is significant, while the risk of failure looms large. Decent returns, but high volatility Within the broader healthcare industry, healthcare equipment manufacturers and…